BlackRock Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.78M | Buy |
25,325
+1,719
| +7% | +$121K | ﹤0.01% | 1833 |
|
|
2016
Q3 | $1.67M | Buy |
23,606
+676
| +3% | +$47.9K | ﹤0.01% | 1729 |
|
|
2016
Q2 | $1.12M | Buy |
22,930
+3,150
| +16% | +$154K | ﹤0.01% | 1905 |
|
|
2016
Q1 | $1.25M | Sell |
19,780
-197,983
| -91% | -$12.5M | ﹤0.01% | 1804 |
|
|
2015
Q4 | $24.4M | Buy |
217,763
+2,362
| +1% | +$265K | 0.01% | 733 |
|
|
2015
Q3 | $20.7M | Buy |
215,401
+108,592
| +102% | +$10.5M | 0.01% | 755 |
|
|
2015
Q2 | $10.9M | Buy |
106,809
+791
| +0.7% | +$81K | 0.01% | 937 |
|
|
2015
Q1 | $6.58M | Buy |
106,018
+4,679
| +5% | +$290K | ﹤0.01% | 1054 |
|
|
2014
Q4 | $4.45M | Buy |
101,339
+2,445
| +2% | +$107K | ﹤0.01% | 1158 |
|
|
2014
Q3 | $5.6M | Buy |
+98,894
| New | +$5.6M | ﹤0.01% | 1061 |
|
|
2014
Q2 | – | Sell |
-22,623
| Closed | -$1.11M | – | 2822 |
|
|
2014
Q1 | $1.11M | Buy |
+22,623
| New | +$1.11M | ﹤0.01% | 1919 |
|